Caliber Partners with Coinbase Prime to Boost Trading and Custody Operations

Caliber, a prominent stock selection platform, has announced that Coinbase Prime will provide complementary services for LINK Treasury’s trading and custody operations. Coinbase Prime, the world-renowned cryptocurrency exchange, will augment Caliber’s trading capabilities and enhance the security of their custody services.

XCHG, the digital currency exchange, has disclosed its first half revenue, reporting a drop from the previous year. The recorded revenue was $12.5 million, a stark contrast to the $20.1 million of the previous year. The reasons for this reduction remain undisclosed.

In a progressive move for digital currency adoption, Sharps Technology has announced a partnership with Jupiter Exchange. The partnership aims to promote the acceptance of Solana, one of the fastest-growing cryptocurrencies, on their respective platforms.

Seres Therapeutics, a leading biopharmaceutical company, has welcomed more constructive feedback from the Food and Drug Administration (FDA) for their investigational therapeutic candidate, SER-155. Though the nature and specifics of the feedback were withheld, this development brings the drug one step closer to potential approval.

The FDA has delivered a Complete Response Letter (CRL) in relation to Scholar Rock’s Biologics License Application (BLA) for apitegromab. A CRL is not an outright rejection; instead, it implies that the regulatory agency requires more information or studies before granting approval to a potential treatment.

The first half earnings per share (EPS) report of Trident Digital shows a decline compared to the same time last year. According to the published data, the company suffered a (2c) loss compared to breaking even during the previous year.

In a significant reshuffle at the executive level, Dr. Doug Buerger has been appointed Chief Operating Officer (COO) at Jiuzi Holdings. Jiuzi will expect to harness Dr. Buerger’s vast experience and in-depth knowledge to drive operational efficiencies and streamline processes.

In exciting news for cancer sufferers, iberdomide, a candidate drug under development by Bristol Myers, has demonstrated signs of improvement during a phase 3 clinical trial for myeloma. While this is still under trial, any progress could be a potential breakthrough in myeloma treatment.

In a move that’s got Wall Street talking, Wendy’s shares have been downgraded by Argus, indicating a bearish turn in the latter’s outlook. While the reasons for this change in stance have not been made clear, it signifies a revised expectation for the performance of Wendy’s shares in the stock market.

AutoZone, a major retailer and distributor of automotive replacement parts, has reported an increase in domestic same-store sales (SSS) for Q4 by 4.8%. This positive financial report highlights the company’s momentum and growing market share in the American automotive market.

Additionally, AutoZone has announced the opening of 91 new stores within the United States during Q4. It’s a clear demonstration of the firm’s aggressive expansion strategy and the targeted efforts in increasing its footprint across the country.

Although having good news on other fronts, disappointment came for AutoZone in the form of Q4 earnings per share (EPS), reported at $48.71, falling short of the anticipated $50.68. The shortfall has opened up severe discussions among analysts and investors.

Canaccord, an independent investment dealer, has increased the price target for Premier by $3.25. Though the exact reasons for this price hike remain undisclosed, it’s a clear indication of Canaccord’s bullish view towards Premier’s potential market performance.

Morgan Stanley, the multinational investment bank, has amped up its optimism towards Hinge Health, raising its price target for the digital health company by an additional $10. This highlights the strong confidence in the positioned growth of Hinge Health in the market.

Investment banking major JPMorgan has raised its price target for Brunswick by $7, revealing a bullish sentiment towards its financial future. This endorsement from a leading bank is expected to have a positive impact on the investor outlook for Brunswick.

Miami International is setting itself up as a new haven for financial futures trading. With a recent announcement of launching support for trading of financial futures, it not only opens up a new market for Miami International but also promises traders and investors a diversity of options.